These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 7533050

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pathophysiology and treatment of negative symptoms.
    Villeneuve A.
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S53-8. PubMed ID: 7533052
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ethical issues in drug selection for schizophrenia.
    Jeffries JJ.
    Can J Psychiatry; 1993 Sep; 38 Suppl 3():S70-4. PubMed ID: 7504571
    [Abstract] [Full Text] [Related]

  • 10. Risperidone: neurochemical, pharmacologic and clinical properties of a new antipsychotic drug.
    Keegan D.
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S46-52. PubMed ID: 7533051
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
    Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652
    [No Abstract] [Full Text] [Related]

  • 13. Dystonic reaction and relapse with clozapine discontinuation and risperidone intiation.
    Dickson R, Williams R, Dalby JT.
    Can J Psychiatry; 1994 Apr; 39(3):184. PubMed ID: 7518338
    [No Abstract] [Full Text] [Related]

  • 14. Risperidone in adolescents.
    Cozza SJ, Edison DL.
    J Am Acad Child Adolesc Psychiatry; 1994 Oct; 33(8):1211. PubMed ID: 7527022
    [No Abstract] [Full Text] [Related]

  • 15. [New psychopharmacologic alternatives in treatment of schizophrenia].
    Bryois C.
    Schweiz Arch Neurol Psychiatr (1985); 1994 Oct; 145(6):19-24. PubMed ID: 7533941
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of a new antipsychotic compound (risperidone): results of a pilot study.
    Möller HJ, Pelzer E, Kissling W, Riehl T, Wernicke T.
    Pharmacopsychiatry; 1991 Nov; 24(6):185-9. PubMed ID: 1725925
    [Abstract] [Full Text] [Related]

  • 17. Risperidone: clinical safety and efficacy in schizophrenia.
    Borison RL, Pathiraja AP, Diamond BI, Meibach RC.
    Psychopharmacol Bull; 1992 Nov; 28(2):213-8. PubMed ID: 1381102
    [Abstract] [Full Text] [Related]

  • 18. Management of treatment refractory schizophrenia.
    Morrison DP.
    Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
    [No Abstract] [Full Text] [Related]

  • 19. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
    Cesková E, Svestka J.
    Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
    [Abstract] [Full Text] [Related]

  • 20. Risperidone for chronic schizophrenia.
    Med Lett Drugs Ther; 1994 Apr 15; 36(920):33-4. PubMed ID: 7511777
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.